Canaccord lowered the firm’s price target on Edgewell Personal Care (EPC) to $32 from $35 and keeps a Buy rating on the shares. The firm said they reported a Q3 miss but as they head into Q4 management expects organic sales to return to growth due to strength in their “Right to Win” portfolio and expectations to grow international.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EPC:
- Edgewell Personal Care: Hold Rating Amidst Valuation Challenges and Future Growth Pressures
- Edgewell upgraded to Equal Weight from Underweight at Morgan Stanley
- Edgewell Personal Care Reports Q3 2025 Earnings
- Edgewell Personal Care Co Faces Challenges Amid Growth
- Edgewell Personal Care reports Q3 adjusted EPS 92c, consensus 99c